October 27, 2023
Foreign investment
China's resilient and complete supply chain provides a strong basis for multinational companies to expand their presence in the country, said a senior executive of AstraZeneca, a United Kingdom-based global pharmaceutical company, underlining its ongoing commitment to scale up investment and enhance local production in China.